Summary.-A randomized trial is reported which evaluates the effect of early diagnostic splenectomy on the prognosis of patients with Hodgkin's disease (HD) and uncertain prognosis. This was started in January 1973 and concluded in April 1979. Sixty-seven patients were entered in the study and 31 were randomized for splenectomy. All patients except 2 received total nodal irradiation, excluding the splenic and hepatic areas. After 40 months' observation there was no difference between the groups in respect of survival and the number of recurrences. However, relapses occurred earlier in the splenectomized patients. Pneumococcal septicaemia was recorded in 2 splenectomized patients. It is concluded that prognosis is not improved by diagnostic splenectomy in HD patients with uncertain prognosis and treated with total nodal irradiation.
EXPLORATORY LAPAROTOMY comprising diagnostic splenectomy with liver and lymphnode biopsy was introduced for the clinical staging of Hodgkin's disease by (Glatstein et al. (1969) . The rationale of this procedure has been supported by the unexpected finding of abdominal involvement in a large proportion of patients resulting in a more extensive treatment (Aisenberg et al., 1971; Meeker et al., 1972; H0st et al., 1973; Rozman et al., 1973; Kaplan et al., 1973; Andersen & Videbaek, 1974; Smithers et al., 1974; B.N.L.I., 1975; Irving, 1975; Somers et al., 1976; Poulsen et al., 1977; Lee et al., 1978) . Hitherto it has been accepted that early detection of advanced disease and the removal of involved spleens in HD should be beneficial to the course of the disease. However, early splenectomy in a group of 21 patients with HD treated with MOPP did not influence duration of survival or longterm remission when compared to historical matched non-splenectomized controls (Panettiere et al., 1977) . No controlled studies are available to elucidate this question in less advanced HD.
This study was undertaken to evaluate the effect of early diagnostic splenectomy on prognosis in HD patients with uncertain prognosis, but without signs of splenic involvement.
MATERIALS AND METHODS
Patients. All previously untreated patients of 15-65 years of age admitted to Radiumhemmet from January 1973 to April 1979 wiere considered for the study. The diagnosis was established by lymphnode biopsy in all patients except 2 who had the diagnosis verified by aspiration biopsy (Bjorkholm et al., 1977a) . The Rye nomenclature was used for lhistological classification (Lukes et al., 1966) : lymphocytic predominance (LP), nodular sclerosis (NS), mixed cellularity (MC) and lymphocytic depletion (LD). All biopsy specimens were reviewed by the same pathologist (GS). These patients received total nodal irradliation, excluding the splenic and hepatic areas, given wvith a 6MeV linear accelerator (Varian) w7ith a mid-plane dose of [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] Gy. After the initial treatment, consisting of mantle field or inverted Y-field irradiation, depending on the first presentation of disease, the patients were stratified into 8 groups according to sex. age (< 35 and 35 ->) and histology (LP, NS and MC, LD) , and w,vere randomized for splenectomy or no splenectomy. After laparotomY the 2nd course of irradiation wAas started [8] [9] [10] weeks after the end of the initial treatment. The interval between the 2 courses of irradiation in the non-splenectomy group was 4-6 weeks. Patients w%vho relapsed wvvere treated with quadruple-drug combination chemotherapy (Bjorkholm et al., 1977a) . Sutrgical procedure. Laparotomy was per-20 formed through a left paramedian incision from the left costal margin to about 5 cm below the umbilical level. The incision allowNed thorough inspection and palpation of the entire abdomen in order to map pathological lymph nodes. Biopsy samples were taken from the areas with lymphographic suspicion of involvement. In cases with negative lymphangiograms, but palpable iliac, para-aortic, coeliac, splenic or mesenteric nodes, biopsy samples were taken, and the sites were marked with metal clips. To avoid complications, large blind dissections were not performed. Before splenectomy the splenic artery was ligated above the pancreas through the lesser sac. Wedge liver biopsy specimens were taken from any suspected area or from the most accessible lobe.
In fertile women, the ovaries were moved and fixed to the back of the neck of the uterus and their lateral corners were marked w%ith metal clips. Oophoropexy was also performed in all fertile women, except in 2 controls.
The spleens were cut in 5mm transverse sections and thoroughly inspected. Biopsy specimens from suspected areas were examined inieroseopically.
RESULTS

The clinical material
At the end of the study, in April 1979, 67 patients had been entered; 31 were randomized for splenectomy and 36 for no splenectomy. The 2 groups were comparable with regard to sex, age, observation time, lymphangiographic findings, clinical stage and histology (Tables I, II and III). As revealed in prospective studies, the immunological capacity evaluated by lymphocyte-function tests (see MATERIALS AND METHODS) is a strong prognostic predictor in HD (Bjorkholm et al., 1977a) . The 2 groups were also comparable with regard to their immune status (Table I) .
The spleen was removed from 29 patients in the splenectomy group (Table II) Early and late surgical complications were found in 4 patients (Table II) . In the non-splenectomy group (Table  III 
Infections
Four severe infections were recorded, 3 in the splenectomy group and 1 in the non-splenectomy group (Tables II, III and  IV) . Case 21 developed generalized herpes zoster and pneumococcal septicaemia during chemotherapy, 6 months after splenectomy. Case 6 suffered a severe but nonfatal pneumococcal septicaemia 34 months after diagnosis. She was in complete remission after chemotherapy for a pulmonary recurrence. Case 30 died from generalized varicella during radiotherapy. In the non-splenectomy group Case 65 died of viral pneumonia. At necropsy no signs of HD were found.
Prognosis
The patients were evaluated at a followup in April 1979, 4-75 months after diagnosis. Relapse rates and patterns were similar in both groups (Tables II and III) Cutler & Ederer (1958) revealed no difference between the groups ( Fig. 1 (Chilcote et al., 1976; Weitzman & Aisenberg, 1977 lower than that of splenic HD in the splenectomized patients ( 11/30; P < 0-001, Fisher's exact test).
The reason so few splenic relapses have appeared is as yet unknown. One possibility is that splenic HD may heal in the absence of disease in other locations. This might parallel the rare occurrence of tumour metastases in the spleen (McLure & Hwa Park, 1975) . Alternatively, the histopathological picture in HD spleens may be a sign of a reactive rather than a malignant process (Amiel & Droz, 1978) . As a 3rd alternative, splenic recurrences in non-splenectomized patients may occur late in the disease, thereby escaping detection during the period of observation. However, the recurrences in the splenectomized group were considerably earlier than those in the non-splenectomized group (Tables II and III) . This is not likely to depend on the longer interval between the mantle and abdominal irradiation in the splenectomized patients, as 6/8 recurrences occurred in the first irradiated area. Moreover, the routine splenectomizing of HD patients before irradiation might favour tumour growth.
It may be concluded that early diagnostic splenectomy in HD under the treatment protocol used in this study does not improve prognosis. Rather, it may lead to surgical complications, increased risk of severe infections and may be associated with earlier relapse of disease.
